<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The National Cooperative Growth Study has monitored the safety of recombinant human GH (rhGH) since 1985 </plain></SENT>
<SENT sid="1" pm="."><plain>Data have been collected from more than 19,000 children representing over 47,000 patient-years of rhGH treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Children receiving GH for <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> were more likely to develop problems such as intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> than those with GH deficiency (P &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Children with idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo> were less likely to develop slipped capital femoral epiphysis than those with GH deficiency or <z:e sem="disease" ids="C0041408" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Turner's syndrome</z:e> (P &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>There was no evidence of an increased recurrence of <z:hpo ids='HP_0001909'>leukemia</z:hpo> or central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>There were 3 new cases of <z:hpo ids='HP_0001909'>leukemia</z:hpo> in children without known risk factors for developing <z:hpo ids='HP_0001909'>leukemia</z:hpo> and 5 cases in children with known risk factors </plain></SENT>
<SENT sid="6" pm="."><plain>Growth deceleration associated with high affinity, high capacity antibodies to GH was found in only 2 of 5039 subjects tested (0.04%) </plain></SENT>
<SENT sid="7" pm="."><plain>Major adverse events in association with rhGH treatment have been rare, and preexisting medical conditions such as <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> may affect their frequency </plain></SENT>
</text></document>